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Abstract
Objective
Many studies have indicated that intra-abdominal pressure (IAP) is positively correlated with
central venous pressure (CVP) in severe cases. However, although elevated IAP is common
in patients with severe acute pancreatitis (SAP), its relationship with CVP remains unclear.
Our study aimed to investigate the association of IAP with CVP in early-phase SAP patients.
Methods
In total, 116 SAP patients were included in this retrospective study. On the first day of hospital-
ization, blood samples were collected for biochemical examination and cytokine concentration
monitoring. Additionally, a urinary catheter and right subclavian vein catheter were inserted for
IAP and CVPmeasurement, respectively. Other routine clinical data were also recorded.
Results
Within 24 hours after hospitalization, CVP fluctuated and increased with increasing IAP up
to 15.7 mmHg (P = 0.054) but decreased with increasing IAP when the IAP was > 15.7
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mmHg (P < 0.001). After adjusting for abdominal perfusion pressure (APP) and mean arteri-
al pressure (MAP), a similar distribution was observed. An inverted U-shaped trend be-
tween IAP and CVP was also present in the groups classified according to the patient’s sex,
local complications, ascites, and serum amylase levels.
Conclusions
CVP and IAP have an inverted U-shaped relationship, with a peak at an IAP of 15.7 mmHg
in the early phase of SAP. After this peak, CVP decreases as IAP increases. These results
have crucial implications for clinical fluid resuscitation in SAP patients. In particular, be-
cause one CVP value might be correlated with different IAP values in patients with the
same CVP, the volume of fluid needed might be different.
Introduction
Acute pancreatitis (AP) is an acute inflammatory process with variable involvement of local tis-
sues and remote organ systems [1]. Elevated intra-abdominal pressure (IAP) is common in the
early phase of AP [2], particularly in patients with severe acute pancreatitis (SAP) [3,4]. Persis-
tent intra-abdominal hypertension (IAH) can lead to complications, including diaphragmatic
compression with reduced pulmonary compliance, renal dysfunction, and intestinal ischemia
[5], all of which can increase mortality from AP.
IAH can also lead to cardiovascular dysfunction. Increased IAP directly compresses the me-
diastinum and inferior vena cava, inducing a low cardiac index [6]. Additionally, over-expres-
sion of inflammatory mediators, such as interleukin (IL)-6, IL-8, and tumor necrosis factor
(TNF)-α, injure the endothelium of the microcirculatory system and subsequently increase
capillary permeability, leading to capillary leakage syndrome [7]. At the same time, the in-
creased capillary permeability leads to fluid loss from the intravascular space and fluid seques-
tration into the third space [8], aggravating the existing IAH. These synergistic effects result in
redistribution of the blood circulation and hypovolemic status. Therefore, early fluid resuscita-
tion is important for reducing morbidity in patients with SAP [9].
Currently, the theory that early goal-directed therapy (EGDT) reduces morbidity and mor-
tality among patients with AP has been accepted worldwide [9–11]. Central venous pressure
(CVP), which is the pressure recorded from the right atrium or superior vena cava, is common-
ly monitored and is frequently used as the major indicator in decisions regarding fluid admin-
istration. In particular, it has been found that CVP is positively correlated with IAP in both
animals and humans [12–15]. However, whether there is a positive relationship between CVP
and IAP in early-phase SAP patients with simultaneous IAH and inadequate circulatory blood
volume is unknown.
Therefore, the aim of this study was to evaluate the relationship between IAP and CVP dur-
ing the early phase of SAP.
Materials and Methods
Data source
All relevant clinical data were extracted from the database of a multi-center, randomized con-
trolled trial (RCT) that was conducted from October 1, 2007, to November 31, 2008, as previ-
ously described [16]. The measurements, including IAP and CVP monitoring and routine
Relationship between CVP and IVP in the Early Stage of SAP
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clinical data collection, were performed based on default protocols. After excluding irrelevant
data, a total of 116 SAP patients from four study sites were enrolled in this retrospective study.
Patients
In this study, all of the participants were adult patients (aged 18 to 70 years old) admitted with-
in 3 days of disease onset. The diagnostic and classification criteria for SAP were in accordance
with the revised Atlanta criteria of 2013 [17], including two of the following features: (1) ab-
dominal pain consistent with AP; (2) amylase activity at least three times greater than the
upper limit of normal; and (3) characteristic findings of AP on contrast-enhanced computed
tomography (CT) and, less commonly, on magnetic resonance imaging or transabdominal ul-
trasonography. Patients who had cardiac failure or pulmonary edema, were pregnant, under-
went early surgical treatment, or presented with other factors that could affect CVP and IAP
were excluded. All of the patients received specialized medical therapy for AP according to the
United Kingdom, Chinese Medical Association, and International Association of Pancreatol-
ogy guidelines [18–20]. Moreover, a urinary catheter and a central venous catheter were
inserted for IAP and CVPmeasurement, respectively. In addition to its use in routine biochem-
ical examination, blood serum was obtained for the analysis of inflammatory cytokines in all
patients. This study was approved by the Medical Ethics Committee of Union Hospital
(Wuhan, China). The need for informed consent was waived by the Medical Ethics Committee
because the study was an observational, retrospective study using a database from which the
patients’ identification information had been removed.
IAP and CVP measurement protocols
1. IAP measurement and IAP grade classification were performed according to the standard
techniques established by the World Society of Abdominal Compartment Syndrome in
2006 [21]. The IAP measurement protocol was as follows: a catheter was inserted into the
bladder; 25 mL of 0.9% saline was instilled, and the midaxillary line was considered to be
level 0. IAP was determined at 10:00, 12:00, and 14:00 on the first day after admission, and
the mean IAP value was calculated as the mean level achieved among the measurements.
The urinary catheter was removed when the patients were in comparatively stable condition
or were suspected of having a urinary tract infection. We present the IAP (mmHg) values
according to the following formula: 1 (cmH2O) = 0.76 (mmHg).
2. The CVP measurement protocol was as follows: a 7-F single-lumen catheter (Arrow In-
ternational Inc., PA, USA) was inserted into the right subclavian vein, and the position of the
catheter tip in the superior vena cava directly adjacent to the right atrium was confirmed
using radiography, if necessary. The CVP catheter was removed when the patients were sus-
pected of having a catheter tip infection. CVP and IAP were measured simultaneously, and
the mean CVP was defined as the mean level achieved among all of the measurements.
Data collection
The factors included in the present investigation were age, sex, cause of illness, IAP, CVP,
mean arterial pressure (MAP), abdominal perfusion pressure (APP; APP = MAP−IAP),
24-hour urine output, and the number of fluid collections on CT (based on blinded radiolo-
gists' reports). APACHE II scores, serum amylase, white blood cell counts, glucose, and
albumin were measured on the first day after admission. MAP and APP were monitored
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simultaneously with IAP and CVP. The fluid balance within the first 24 hours was also calcu-
lated. CT grade classification was assessed according to Balthazar’s methods [22]. Local com-
plications, such as acute peripancreatic fluid collection, acute necrotic collection and
pancreatic pseudocysts, were recorded. Serum high-sensitivity C-reactive protein (hs-CRP)
and inflammatory cytokine density were measured in the Central Laboratory of Wuhan Union
Hospital. Serum hs-CRP density were measured using a Cobas Integra 800 instrument (Roche,
Basel, Switzerland). The serum densities of IL-1, IL-6, IL-8, and TNF-α were measured using
enzyme-linked immunosorbent assays (R&D Systems, Minneapolis, MN, USA) according to
the manufacturer’s instructions.
Statistical analysis
Both univariate and multivariate logistic regression analyses were performed. CVP was mea-
sured in cmH2O. We first divided the patients into three groups according to their CVP values
and then examined the inter-group differences with regard to the patients’ general conditions,
liver and renal function, inflammatory cytokine density, IAP values, CVP values, CT grades,
and APACHE II scores. The descriptive results of the analysis of normally distributed data are
expressed as the means ± standard deviations, and medians (ranges) were evaluated using one-
way ANOVA or the Kruskal test (rank-sum test). Chi-square analysis was also performed for
categorical variables, and non-normally distributed values were evaluated using the Mann-
Whitney U test.
We used a linear regression model to identify potential confounders and then created a scat-
ter plot of CVP (cmH2O) versus IAP (mmHg). We also created a scatter-plot of CVP (cmH2O)
versus IAP (mmHg) within different groups categorized according to the following variables:
sex (male or female), local complications (no or yes), ascites (no or yes), and amylase density
(low or high, according to the median value).
We then applied a generalized additive model using a spline smoothing function to examine
the relationship between CVP and IAP, and we conducted piecewise linear regression analysis
to fit the smoothing curve, with adjustment for potential confounders. The turning points con-
necting the piecewise lines were determined by trial and error, including the selection of turn-
ing points along a pre-defined interval and the choice of turning points that yielded the
maximum likelihood model. The piecewise linear model was then tested using a log-likelihood
ratio test against the one-line linear regression model.
Finally, we applied multiple regression analyses to estimate the correlation coefficient and
95% confidence interval (CI) between IAP and CVP, with adjustment for potential confound-
ers. All of the analyses were performed using Empower(R) (www.empowerstats.com, X&Y So-
lutions, Inc., Boston, MA, USA) and R (http://www.R-project.org) software, as described by Yu
et al. [23]. The missing data are described as "NA" as per Empower(R) requirements. A value of
P< 0.05 was considered statistically significant.
Results
A total of 116 patients were included in the study. On the first day of admission, there were 76
(65.5%), 21 (18.1%) and 7 (6.03%) patients who suffered from respiratory, renal and cardiovas-
cular failure, respectively. Fifty-eight (50.0%) developed persistent respiratory failure, and 9
(7.76%) developed persistent renal failure. According to the revised Atlanta definitions and
classifications, 52 (44.8%) patients presented with moderate SAP and 64 (55.2%) patients pre-
sented with SAP. Sixty-nine (59.5%) patients presented with one or more local complications,
and 15 (12.9%) patients presented with moderate to large ascites in the peritoneal cavity. The
mean IAP, MAP, APP, and CVP of the patients in this study were 12.3 mmHg, 98.2 mmHg,
Relationship between CVP and IVP in the Early Stage of SAP
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85.8 mmHg and 9.9 cmH2O, respectively. The mean age was 47.2 ± 11.9 years. The mean urine
output during the first 24 hours after admission was 2642 ± 1624 mL. The mean serum alanine
transaminase (ALT) and aspartate transaminase (AST) densities were 57.0 ± 83.1 U/L and
58.3 ± 95.4 U/L, respectively. The mean serum BUN and Cr values were 5.7 ± 2.7 mmol/L and
82.4 ± 35.1 μmol/L, respectively. Table 1 shows the characteristics of the study population ac-
cording to CVP, and Fig 1 shows the distribution of the mean IAP.
Fig 2 is a scatter plot of CVP (cmH2O) versus IAP (mmHg). The curve shows that the rela-
tionship between CVP and IAP was not simply linear; rather, CVP fluctuated and increased
with increasing IAP up to an IAP of approximately 16 mmHg. In particular, as shown in
Table 2, threshold effect analysis indicated that CVP increased with increasing IAP up to an
IAP of 15.7 mmHg. In patients with an IAP 15.7 mmHg, CVP was not significantly associat-
ed with IAP (β = 0.21, 95% CI: 0.00 to 0.40, P = 0.054). In patients with an IAP> 15.7 mmHg,
the correlation coefficient (β) of CVP was negative (β = -2.12, 95% CI: −2.67 to −1.57,
P< 0.001).
Table 3 shows the associations between CVP and IAP based on a multiple regression model
adjusted for MAP and APP. CVP was marginally significantly positively associated with IAP (β
= 0.20, 95% CI: 0.01 to 0.41, P = 0.059) in patients with an IAP 15.7 mmHg. However, in pa-
tients with an IAP> 15.7 mmHg, the correlation coefficient of CVP was negative (β = −2.14,
95% CI: −3.42 to −0.85, P = 0.005). This result demonstrated that CVP increased among pa-
tients with AP who had an IAP 15.7 mmHg. However, when the IAP of patients with AP
was> 15.7 mmHg, the CVP decreased. After adjusting for APP and MAP, a similar distribu-
tion was still observed. In addition, an inverted U-shaped relationship between CVP and IAP
was observed when the patients were classified according to sex, local complications, ascites,
and serum amylase values (see Fig 3).
Table 4 shows the characteristics of the study population according to IAP levels. Patients
with IAP values>15.7 mmHg exhibited higher APACHE II scores (P< 0.001), higher hs-CRP
levels (P = 0.011), more balanced fluid amounts (P = 0.018), and lower SPO2 levels (P = 0.033).
Discussion
Our study demonstrated that the relationship between CVP and IAP in the early phase of SAP
was not a simple linear correlation. Further threshold effect analysis demonstrated that CVP
and IAP had an inverted U-shaped relationship, with the peak IAP at 15.7 mmHg (approxi-
mately grade II IAH). After the peak value, CVP decreased as IAP increased. This relationship
was marginally significant (β = 0.20, 95% CI: 0.00 to 0.40, P = 0.054). However, in patients with
a higher IAP (IAP> 15.7 mmHg), the correlation between IAP and CVP was significantly neg-
ative (β = −2.12, 95% CI: −2.67 to −1.57, P< 0.001). A similar inverted U-shaped relationship
between CVP and IAP was still found after adjusting for APP and MAP, and it persisted in the
groups classified according to the patient’s sex, local complications, ascites, and serum amylase
value.
CVP is frequently used for the assessment of cardiac preload and volume status [24]. Previ-
ously, many studies have documented a positive correlation between IAP and CVP [14,15,25].
For example, Kuntscher et al. reported that the CVP level was positively correlated with IAP in
patients with major burns [26]. However, in the present study, we found that the relationship
between IAP and CVP was not linear but rather formed an inverted U-shape. One reason for
this difference was that our subjects were patients with AP who had more severe capillary per-
meation than other critical patients with the same IAP levels.
IAP, an early marker of AP severity, is closely correlated with capillary permeation in pa-
tients with SAP [3,27]. Moreover, several studies have indicated that IAH was associated with
Relationship between CVP and IVP in the Early Stage of SAP
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Table 1. Characteristics of the study population by central venous pressure quartiles.
Q1 (CVP <5) Q2 (5CVP<12) Q3 (CVP12) P value P value*
Patients, n 7 81 28
Age, year 46.4 (16.8) 47.2 (12.0) 47.3 (10.4) 0.986 0.937
Gender 0.236 0.261
Male 6 (85.7%) 48 (59.3%) 20 (71.4%)
Female 1 (14.3%) 33 (40.7%) 8 (28.6%
Height, cm 170.6 (7.4) 166.5 (7.7) 165.7 (6.5) 0.3 0.226
BUN, mmol/L 5.1 (3.0) 5.5 (2.5) 6.4 (3.0) 0.23 0.247
Cr, μmol/L 74.2 (30.9) 78.7 (31.3) 95.0 (43.8) 0.087 0.197
ALT, U/L 33.7 (18.5) 54.8 (79.8) 69 (100.8) 0.556 0.643
AST, U/L 28.4 (14.7) 57.8 (102.5) 67.1 (85.1) 0.633 0.15
Fluid balance (24h), ml 1068.6 (758.2) 584.9 (1273.0) 509.1 (1234.0) 0.564 0.46
Urine, ml 2571.4 (1014.4) 2495.1 (1490.1) 3082.5 (2022.1) 0.254 0.377
BE, mmol/L -4.6 (4.1) -3.3 (4.7) -4.6 (3.4) 0.359 0.059
SPO2, % 74.3 (24.7) 79.8 (24.0) 73.5 (24.1) 0.451 0.095
APACHE II score 23.9 (5.0) 12.5 (4.9) 11.1 (2.9) <0.001 <0.001
Serum amylase, U/L 529.9 (345.6) 701.2 (599.3) 787.1 (667.7) 0.582 0.735
hs-CRP, μg/ml 190.3 (15.0) 176.9 (95.2) 240.7 (111.0) 0.019 0.037
IL-1, pg/ml 19.2 (5.9) 24.5 (15.8) 21.6 (13.6) 0.492 0.614
IL-6, pg/ml 29.8 (18.9) 52.1 (61.2) 67.0 (52.5) 0.265 0.032
IL-8, pg/ml 69.7 (84.4) 29.3 (27.6) 29.4 (20.6) 0.007 0.498
TNF-α, pg/ml 70.3 (65.1) 43.0 (19.4) 35.6 (13.1) 0.003 0.088
IAP, mmHg 18.4 (1.0) 11.8 (2.9) 12.3 (2.1) <0.001 <0.001
CVP, cmH2O 3.6 (0.7) 9.2 (1.5) 13.5 (1.5) <0.001 <0.001
MAP, mmHg 92.4 (8.4) 97.1 (10.5) 102.8 (11.4) 0.019 0.002
APP, mmHg 74.0 (7.6) 85.3 (10.7) 90.5 (11.6) 0.001 <0.001
HR, n/min 116.0 (9.9) 97.2 (17.0) 107.2 (17.3) 0.001 <0.001
RBC, /L 4.1 (0.8) 6.0 (11.0) 4.9 (0.8) 0.789 0.065
CT grade, score 0.037 0.033
3 7 (100%) 50 (62.5%) 11 (39.3%)
4 0 (0%) 5 (6.2%) 4 (14.3%)
5 0 (0%) 25 (31.2%) 13 (46.4%)
Ascites 0.96 0.899
No 6 (85.7%) 71 (87.7%) 24 (85.7%)
Yes 1 (14.3%) 10 (12.3%) 4 (14.3%)
Local complication 0.06 0.077
No 1 (14.3%) 30 (37.0%) 16 (57.1%)
Yes 6 (85.7%) 51 (63.0%) 12 (42.9%)
CVP: central venous pressure; IAP: intra-abdominal pressure; MAP: mean arterial pressure; APP: abdominal perfusion pressure; HR: heart rate; Ascites:
moderate-to-large ﬂuid collections in the peritoneal cavity detected by B type ultrasonography or CT scans; APACHE II score: Acute Physiology and
Chronic Health Evaluation II score; BE: base excess; CT grade: according to Balthazar's methods; Local complication: including pancreatic necrosis,
pseudocyst and abscess.
P value*: Kruskal Wallis rank sum test was used to examine the signiﬁcance if the variable was continuous. If theoretical number of the enumeration data
<10, Fisher's exact test was used to calculate the signiﬁcance.
[mean (SD) and median (min-max) or n(%)]
doi:10.1371/journal.pone.0128493.t001
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high rates of pancreatic infection, septic shock, organ dysfunction, and mortality in patients
with SAP [12,28–30]. In our study, patients with IAP values>15.7 mmHg exhibited higher
APACHE II scores (P< 0.001), higher hs-CRP levels (P = 0.011), more balanced fluid amounts
(P = 0.018), and lower SPO2 levels (P = 0.033) (Table 4). As IAP increased, capillary permeabil-
ity increasingly worsened, resulting in a lower blood volume. Once the “volume-decreasing ef-
fect” exceeded the “pressure-increasing effect”, CVP did not increase but rather decreased with
increasing IAP.
Our study has potential implications for early fluid resuscitation in patients with SAP. CVP
monitoring is widely used in clinical work for the assessment of cardiac preload and volume
status [31]. Dellinger et al. stated that CVP should continue to be recommended to guide fluid
resuscitation [32,33]. Additionally, Mayerle et al. recommended that CVP, combined with the
urine excretion rate and daily hematocrit, should be closely monitored and that CVP should
be increased to a level between 8 and 12 cmH2O for the management of AP patients [34].
Moreover, certain researchers have reported that the CVP could be used to gauge fluid balance
within 12 hours after onset in septic shock patients [35]. Because of the effects of IAP, the mon-
itored CVP value should be adjusted to the real value for fluid resuscitation. Most previous
studies have reported that the CVP level was positively correlated with IAP in critical patients
Fig 1. Bar chart representing the frequency of different grades of IAH according to theWorld Society
for Abdominal Compartment syndrome guidelines. Normal: IAP<12mmHg; GradeI IAH: IAP between 12
to 15 mmHg. GradeII IAH: IAP between 16 to 20 mmHg. GradeIII IAH: IAP between 21 to 25 mmHg. GradeIV
IAH: IAP greater than 25 mmHg. IAP: intra-abdominal pressure, IAH: intra-abdominal hypertension.
doi:10.1371/journal.pone.0128493.g001
Fig 2. Scatter plot and smoothing curve of IAP (mmHg) by CVP (cmH2O).
doi:10.1371/journal.pone.0128493.g002
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[1–4]. Based on this previously reported correlation between IAP and CVP, it was recom-
mended that clinical practitioners adjust the real value for fluid resuscitation. However, our
study indicated that there was an inverted U-shaped relationship between CVP and IAP in the
early phase of AP, indicating that the same CVP level might be present in patients with SAP
that have different levels of IAP and varying severity of disease. Accordingly, when adjusting
the monitored CVP value to the real value for fluid resuscitation, both disease severity and in-
creasing IAP should be considered. Thus, in the case of two patients with the same CVP, a larg-
er volume of fluid is needed for resuscitation in the patient with the higher IAP level.
In recent years, the theory that CVP could be used to guide fluid therapy has been chal-
lenged. In fact, several studies have demonstrated that CVP did not reflect the body’s blood vol-
ume and, therefore, that CVP should not be used to make clinical decisions regarding fluid
management [36–38]. In a recently published meta-analysis, Marik et al. specifically stated that
CVP should not be used to make clinical decisions regarding fluid management because this
parameter alone did not improve upon earlier methods that served as a guide for fluid resusci-
tation [39]. Our study also showed that CVP could remain the same at different IAP values,
suggesting that CVP is unreliable as the sole indicator of the need for fluid management. How-
ever, we maintain that CVP should still be used as an important index for fluid resuscitation.
Table 2. Threshold effect analysis of IAP in CVP using piecewise linear regression model.
Model Result[β (95%CI) P value]
Model I one-line linear regression model -0.31 (-0.47, -0.15) <0.001
Model II turning point 15.7
group1: IAP  15.7, correlation coefﬁcient (β1) 0.21 (0.00, 0.41) 0.054
group2: IAP > 15.7, correlation coefﬁcient (β2) -2.12 (-2.67, -1.57) <0.001
β2-β1 -2.32 (-3.01, -1.63) <0.001
a log likelihood ratio test <0.001
predictive value of CVP at turning point 11.37 (10.4, 12.34)
Outcome variance: CVP (cmH2O); Risk factor: IAP (mmHg).
doi:10.1371/journal.pone.0128493.t002
Table 3. Adjusted Effect of IAP on CVP [β (95%CI) P value].
correlation coefﬁcient (β) 95%CI P value
IAP group 1 (IAP15.7)
Model I 0.2 -0.01, 0.41 0.059
Model II 0.22 0.01, 0.42 0.042
Model III 0.18 -0.03, 0.39 0.094
IAP group 2 (IAP>15.7)
Model I -2.14 -3.42, -0.85 0.005
Model II -1.9 -2.73, -1.06 <0.001
Model III -2.128 -2.30, -1.294 <0.001
Outcome variance: CVP (cmH2O); risk factor: IAP (mmHg).
Model I: Multiple regression model (no adjusted related risk factors);
Model II: Multiple regression model adjusted APP level;
Model III: Multiple regression model adjusted MAP level.
CVP: central venous pressure; IAP: intra abdominal pressure; MAP: mean arterial pressure; APP:
abdominal perfusion pressure.
doi:10.1371/journal.pone.0128493.t003
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Currently, the theory that EGDT is important for reducing morbidity and mortality among pa-
tients with AP is accepted worldwide [9–11]. In 2013, the acute pancreatitis management
guidelines issued by the American College of Gastroenterology indicated that early and aggres-
sive intravenous hydration was most beneficial within the first 12–24 hours of onset and might
have little benefit for AP patients beyond this time [40]. Although the gold standard for fluid
resuscitation in SAP patients remains unspecified, the criteria used worldwide for fluid resusci-
tation in patients with SAP are commonly combinations of indices, including factors such as
Fig 3. Smoothing curve of CVP (cmH2O) by IAP (mmHg) in different groups considering. A: patients'
gender; B: local complication; C: ascites; D: serum amylase.
doi:10.1371/journal.pone.0128493.g003
Table 4. Characteristics of the study population by intra-abdomnal pressure quartiles.
Q1 (IAP15.7 mmHg) Q2 (IAP>15.7 mmHg) P
Patients, n 99 17 —
APACHE II score 11.7±3.7 19.8±7.6 <0.001
hs-CRP, μg/ml 184.7±101.7 235±74.5 0.011
Balance amount, mL 497±1275 1168±801 0.018
SPO2, % 79.5±23.6 68.8±25.1 0.033
CT grade (n,%) 0.090*
3 54 (55.1) 14 (82.4)
4 9 (9.2) 0 (0.0)
5 35 (35.7) 3 (17.6)
TNF-α, pg/ml 41.2±18.8 52.7±43.6 0.255
APP, mmHg 99.2±18.5 113.7±11.1 0.002*
MAP, mmHg 98.7±11.1 96.9±11.8 0.513
Urine, mL 2671±1710 2442±883 0.572
RBC, /L 5.8±9.9 4.5±0.8 0.581
Q1: the patients with IAP15.7mmHg; Q2: the patients with IAP>15.7 mmHg.
P: value from Kruskal Test (rank sum test);
*P: value from ANOVA.
RBC: count of red blood cell; APACHE II score: Acute Physiology and Chronic Health Evaluation II score; APP: abdominal perfusion pressure; MAP:
mean arterial pressure.
[mean±SD or n(%)]
doi:10.1371/journal.pone.0128493.t004
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pulse, blood pressure, urine output, CVP, and MAP [41,42]. In our previous RCT, the criteria
for fluid resuscitation among patients with SAP were as follows: CVP, 8–15 mmHg; urine out-
put, 0.5 mLkg−1h−1; MAP, 65 mmHg; heart rate, 80–110 bpm; hematocrit, 0.3; and ve-
nous oxygen saturation, 0.70 [16]. Clinically, we have also adopted the same indices, which
have proved to be helpful in relieving symptoms. Therefore, we maintain that, although the
CVP value alone is not sufficient to reflect the body's blood volume or even to guide fluid resus-
citation, CVP combined with other indices remains important for guiding fluid resuscitation.
Further studies are needed to develop a sound theory as groundwork for detailed guidelines for
SAP patients.
There were certain limitations to our study. First, it was designed as a retrospective study
and involved only a Chinese population. Further research is needed that includes other poten-
tial confounding factors that could influence the relationship between IAP and CVP in patients
with early-phase AP, including differences in characteristics between Chinese populations and
other populations, such as disease etiology and body mass index. Second, the number of pa-
tients included was limited (n = 116), and only 17 patients had an IAP level> 15.71 mmHg.
Despite the trend toward CVP increasing and then decreasing with increasing IAP in different
groups classified according to the patient’s sex and APACHE II scores, the associations be-
tween CVP and IAP became non-significant after adjusting for certain factors (P = 0.154, after
adjusting for the hs-CRP level, local complications, and the IL-6 level). Future studies should
include more patients, particularly more patients with higher IAP levels, to validate the rela-
tionship between IAP and CVP. Third, our study only included data from the first day of hos-
pitalization in patients with SAP. Whether a similar relationship between IAP and CVP
persists later also merits further investigation. The fourth limitation was that the specific reason
for the inverted U-shaped relationship between CVP and IAP was not revealed in this observa-
tional study; therefore, future animal and clinical studies should be initiated to determine the
mechanism underlying this relationship.
Conclusions
This study suggested that CVP and IAP had an inverted U-shaped relationship, with the peak
IAP at 15.7 mmHg in early-phase SAP patients. After this peak, CVP decreased as IAP in-
creased. An inverted U-shaped relationship between CVP and IAP was also observed after ad-
justing for APP and MAP, and this shape persisted in the different groups classified according
to the patient’s sex, local complications, ascites, serum amylase, CT grades, and APACHE II
scores. These results have crucial implications for clinical fluid resuscitation in SAP patients. In
particular, because one CVP value might be correlated with different IAP values in SAP pa-
tients with the same CVP, the amount of fluid required might be different.
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